학술논문

PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB (R) 5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Document Type
Journal
Source
ANNALS OF THE RHEUMATIC DISEASES; JUN 2019, 78 p761-p762, 2p. Supplement: 2
Subject
Language
English
ISSN
14682060